BCR and mantle cell lymphoma: Furthermore, blockage of BCR signaling could reduce MCL-cell homing into microenvironment in lymphoid organs or bone marrow and thereby inhibiting MCL-cell survival, which was considered as the predominant action of BTKi [6].